Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.
The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.
The disease's painful symptoms are often treated with prescription opioids. But a new clinical trial has found that cannabis could be a promising, and safer, substitute.
The Colorado Department of Agriculture has once again expanded its list of pesticides approved for use on cannabis crops.
Before the 'reefer-endum' arrives, the country's legalization bill could still benefit from a few edits, say leading addiction researchers.
The study found that these claims were more common in US states that listed opioid use disorder as a qualifying condition for medical cannabis.
To help decide what to do with the impounded products, state authorities are welcoming input from the public until July 15.